カテゴリー： 世界, 医療/バイオ, Research Dive

世界のコンパニオンアニマル関節炎市場2022年-2031年：コンパニオン種類別（犬、猫、馬）、関節炎種類別（変形性関節症、関節リウマチ）、治療別（運動、医療、その他）、流通チャネル別（オンラインストア、ペット用品店、動物病院＆診療所、その他）

【英語タイトル】Companion Animal Arthritis Market by Companion Type (Dog, Cat, and Horse), Arthritis Type (Osteoarthritis and Rheumatoid Arthritis), Treatment (Exercise, Medical, and Others), and Distribution Channel (Online Store, Pet Supply Store, Veterinary Hospitals and Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2022–2031

Research Diveが出版した調査資料（RDV23MA018）・商品コード：RDV23MA018
・発行会社（調査会社）：Research Dive
・発行日：2022年12月18日
・ページ数：250
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：生命科学
◆販売価格オプション（消費税別）
Single UserUSD5,700 ⇒換算￥866,400見積依頼/購入/質問フォーム
5 UserUSD8,700 ⇒換算￥1,322,400見積依頼/購入/質問フォーム
Enterprise UserUSD10,700 ⇒換算￥1,626,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Research Dive社の本調査レポートでは、世界のコンパニオンアニマル関節炎市場規模が2021年2,875.5百万ドルから2031年には5,520.5百万ドルに達し、年平均7.0%成長すると予測しています。本レポートは、コンパニオンアニマル関節炎の世界市場について調査を行い、調査手法、調査範囲、エグゼクティブサマリー、市場概要、コンパニオン種類別（犬、猫、馬）分析、関節炎種類別（変形性関節症、関節リウマチ）分析、治療別（運動、医療、その他）分析、流通チャネル別（オンラインストア、ペット用品店、動物病院＆診療所、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況などの項目をまとめています。なお、企業情報には、Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, CEVA Logistics, Dechra Pharmaceuticals plc., Vetoquinol, NexGen Pharmaceuticals, and Norbrook.などが含まれています。
・調査手法
・調査範囲
・エグゼクティブサマリー
・市場概要
・世界のコンパニオンアニマル関節炎市場規模：コンパニオン種類別
- 犬における市場規模
- 猫における市場規模
- 馬における市場規模
・世界のコンパニオンアニマル関節炎市場規模：関節炎種類別
- 変形性関節症の市場規模
- 関節リウマチの市場規模
・世界のコンパニオンアニマル関節炎市場規模：治療別
- 運動治療の市場規模
- 医療の市場規模
- その他治療の市場規模
・世界のコンパニオンアニマル関節炎市場規模：流通チャネル別
- オンラインストアチャネルの市場規模
- ペット用品店チャネルの市場規模
- 動物病院＆診療所チャネルの市場規模
- その他チャネルの市場規模
・世界のコンパニオンアニマル関節炎市場規模：地域別
- 北米のコンパニオンアニマル関節炎市場規模
- ヨーロッパのコンパニオンアニマル関節炎市場規模
- アジア太平洋のコンパニオンアニマル関節炎市場規模
- 中南米のコンパニオンアニマル関節炎市場規模
- 中東/アフリカのコンパニオンアニマル関節炎市場規模
・競争状況
・企業情報

According to Research Dive analysis, the global companion animal arthritis market is anticipated to generate revenue of $5,520.5 million by 2031, increasing from $2,875.5 million in 2021, at a CAGR of 7.0%.

COVID-19 Impact on Global Companion Animal Arthritis Market:
The global companion animal arthritis industry has faced huge challenges during the COVID-19 pandemic, owing to low veterinary clinic admission due to the cancellation of routine pet checkups which have reduced the number of arthritis surgeries performed by veterinary hospitals. This is because a majority of pet owners have delayed going to veterinary clinics. Governments and veterinary organizations across several countries adopted plans and safety measures to restart veterinary activities during the pandemic. To mitigate the impact of lockdowns, the American Veterinary Medical Association, reported that many veterinary clinics and hospitals have opted for telemedicine services to maintain the social distancing norms to avoid the spread of the COVID-19 virus.

Companion Animal Arthritis Market Analysis:
An increase in the number of cases of arthritis and growing awareness regarding animal healthcare is estimated to boost the companion animal arthritis market size during the forecast period. Arthritis that causes inflammation of joints is commonly seen in dogs that causes discomfort, pain, and stiffness. Arthritis is a common condition usually seen in dogs that leads to abnormal cartilage development, joint instability, and can cause fractures. Arthritis condition requires regular treatment throughout life that reduces cartilage damage, minimizes painful inflammation, and promotes the repair of joint structures.

The uncertainties brought by the COVID-19 pandemic owing to the lockdown restrictions and limited access to veterinary services due to fear of the spread of coronavirus. The closure of veterinary services due to the cancellation of veterinary appointments is estimated to restrict the companion animal arthritis market share during the forecast period.
The FDA’s fast approval of veterinary regenerative medicine and veterinary therapeutic pharmaceuticals to treat arthritis conditions will open up new avenues for the market growth rate. Furthermore, an increase in awareness about canine health is expected to accelerate the growth rate of the companion animal arthritis market in the future. The increase in the cost of pet care in both, emerging and established nations represents a huge opportunity for the industry expansion. The American Kennel Club (AKC) reports that pet owners in the U.S. are spending more money on their pets’ wellness and related healthcare goods. According to the American Pet Products Association, the entire pet business sale has increased.
By companion type, the dog segment is predicted to show the fastest growth rate. Arthritis is commonly seen in dogs and is caused due to overweight, injuries, and immature bone development. A rapid increase in the rate of dog ownership across major countries is estimated to boost market growth. As per analysis, 33% of the American households own at least one dog.

By arthritis type, the osteoarthritis segment accounted for the highest market share in 2021. Osteoarthritis is a complex condition that causes inflammation and degeneration of one or more joints. This condition is diagnosed via thorough physical examination and diagnostics such as x-ray and other imaging technologies.
By treatment, the medical segment accounted for the highest market size in 2021 and it is estimated to show the fastest growth during the forecast period. This is because arthritis is majorly treated via medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) that helps in reducing joint pain and inflammation.
By distribution channel, the pet supply store segment accounted for the highest market share in 2021. This is because pet supply stores offer a range of pet supplies ranging from supplements, medications, food toys, grooming, and other products at a reasonable price.
By geographical scope, the North America companion animal arthritis market accounted for the highest market size in 2021. This growth is majorly owing to an increase in awareness regarding pet care that helps in reducing joint pain and stiffness.
Companies involved in the global companion animal arthritis market are Zoetis, Virbac, Elanco, Boehringer Ingelheim International GmbH, CEVA Logistics, Dechra Pharmaceuticals plc., Vetoquinol, NexGen Pharmaceuticals, and Norbrook.

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1.Research Methodology

1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation

1.5.1.Top-down approach
1.5.2.Bottom-up approach

2.Report Scope

2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on global Companion Animal Arthritis market

3.Executive Summary

4.Market Overview

4.1.Introduction
4.2.Growth impact forces

4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities

4.3.Market value chain analysis

4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors

4.4.Innovation & sustainability matrices

4.4.1.Technology matrix
4.4.2.Regulatory matrix

4.5.Porter’s five forces analysis

4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity

4.6.PESTLE analysis

4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental

4.7.Impact of COVID-19 on Companion Animal Arthritis market

4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario

5.Companion Animal Arthritis Market Analysis, by Companion Type

5.1.Overview

5.2.Dog

5.2.1.Definition, key trends, growth factors, and opportunities
5.2.2.Market size analysis, by region
5.2.3.Market share analysis, by country

5.3.Cat

5.3.1.Definition, key trends, growth factors, and opportunities
5.3.2.Market size analysis, by region
5.3.3.Market share analysis, by country

5.4.Horse

5.4.1.Definition, key trends, growth factors, and opportunities
5.4.2.Market size analysis, by region
5.4.3.Market share analysis, by country

5.5.Research Dive Exclusive Insights

5.5.1.Market attractiveness
5.5.2.Competition heatmap

6.Companion Animal Arthritis Market Analysis, by Arthritis Type

6.1.Osteoarthritis

6.1.1.Definition, key trends, growth factors, and opportunities
6.1.2.Market size analysis, by region
6.1.3.Market share analysis, by country

6.2.Rheumatoid Arthritis

6.2.1.Definition, key trends, growth factors, and opportunities
6.2.2.Market size analysis, by region
6.2.3.Market share analysis, by country

6.3.Research Dive Exclusive Insights

6.3.1.Market attractiveness
6.3.2.Competition heat map

7.Companion Animal Arthritis Market Analysis, by Treatment

7.1.Exercise

7.1.1.Definition, key trends, growth factors, and opportunities
7.1.2.Market size analysis, by region
7.1.3.Market share analysis, by country

7.2.Medical

7.2.1.Definition, key trends, growth factors, and opportunities
7.2.2.Market size analysis, by region
7.2.3.Market share analysis, by country

7.3.Other

7.3.1.Definition, key trends, growth factors, and opportunities
7.3.2.Market size analysis, by region
7.3.3.Market share analysis, by country

7.4.Research Dive Exclusive Insights

7.4.1.Market attractiveness
7.4.2.Competition heat map

8.Companion Animal Arthritis Market Analysis, by Distribution Channel

8.1.Online Store

8.1.1.Definition, key trends, growth factors, and opportunities
8.1.2.Market size analysis, by region
8.1.3.Market share analysis, by country

8.2.Pet Supply Store

8.2.1.Definition, key trends, growth factors, and opportunities
8.2.2.Market size analysis, by region
8.2.3.Market share analysis, by country

8.3.Veterinary Hospitals and Clinics

8.3.1.Definition, key trends, growth factors, and opportunities
8.3.2.Market size analysis, by region
8.3.3.Market share analysis, by country

8.4.Others

8.4.1.Definition, key trends, growth factors, and opportunities
8.4.2.Market size analysis, by region
8.4.3.Market share analysis, by country

8.5.Research Dive Exclusive Insights

8.5.1.Market attractiveness
8.5.2.Competition heat map

9.Companion Animal Arthritis Market, by Region

9.1.North America

9.1.1.U.S.

9.1.1.1.Market size analysis, by Companion Type
9.1.1.2.Market size analysis, by Arthritis Type
9.1.1.3.Market size analysis, by Treatment
9.1.1.4.Market size analysis, by Distribution Channel

9.1.2.Canada

9.1.2.1.Market size analysis, by Companion Type
9.1.2.2.Market size analysis, by Arthritis Type
9.1.2.3.Market size analysis, by Treatment
9.1.2.4.Market size analysis, by Distribution Channel

9.1.3.Mexico

9.1.3.1.Market size analysis, by Companion Type
9.1.3.2.Market size analysis, by Arthritis Type
9.1.3.3.Market size analysis, by Treatment
9.1.3.4.Market size analysis, by Distribution Channel

9.1.4.Research Dive Exclusive Insights

9.1.4.1.Market attractiveness
9.1.4.2.Competition heatmap

9.2.Europe

9.2.1.Germany

9.2.1.1.Market size analysis, by Companion Type
9.2.1.2.Market size analysis, by Arthritis Type
9.2.1.3.Market size analysis, by Treatment
9.2.1.4.Market size analysis, by Distribution Channel

9.2.2.UK

9.2.2.1.Market size analysis, by Companion Type
9.2.2.2.Market size analysis, by Arthritis Type
9.2.2.3.Market size analysis, by Treatment
9.2.2.4.Market size analysis, by Distribution Channel

9.2.3.France

9.2.3.1.Market size analysis, by Companion Type
9.2.3.2.Market size analysis, by Arthritis Type
9.2.3.3.Market size analysis, by Treatment
9.2.3.4.Market size analysis, by Distribution Channel

9.2.4.Spain

9.2.4.1.Market size analysis, by Companion Type
9.2.4.2.Market size analysis, by Arthritis Type
9.2.4.3.Market size analysis, by Treatment
9.2.4.4.Market size analysis, by Distribution Channel

9.2.5.Italy

9.2.5.1.Market size analysis, by Companion Type
9.2.5.2.Market size analysis, by Arthritis Type
9.2.5.3.Market size analysis, by Treatment
9.2.5.4.Market size analysis, by Distribution Channel

9.2.6.Rest of Europe

9.2.6.1.Market size analysis, by Companion Type
9.2.6.2.Market size analysis, by Arthritis Type
9.2.6.3.Market size analysis, by Treatment
9.2.6.4.Market size analysis, by Distribution Channel

9.2.7.Research Dive Exclusive Insights

9.2.7.1.Market attractiveness
9.2.7.2.Competition heatmap

9.3.Asia-Pacific

9.3.1.China

9.3.1.1.Market size analysis, by Companion Type
9.3.1.2.Market size analysis, by Arthritis Type
9.3.1.3.Market size analysis, by Treatment
9.3.1.4.Market size analysis, by Distribution Channel

9.3.2.Japan

9.3.2.1.Market size analysis, by Companion Type
9.3.2.2.Market size analysis, by Arthritis Type
9.3.2.3.Market size analysis, by Treatment
9.3.2.4.Market size analysis, by Distribution Channel

9.3.3.India

9.3.3.1.Market size analysis, by Companion Type
9.3.3.2.Market size analysis, by Arthritis Type
9.3.3.3.Market size analysis, by Treatment
9.3.3.4.Market size analysis, by Distribution Channel

9.3.4.Australia

9.3.4.1.Market size analysis, by Companion Type
9.3.4.2.Market size analysis, by Arthritis Type
9.3.4.3.Market size analysis, by Treatment
9.3.4.4.Market size analysis, by Distribution Channel

9.3.5.South Korea

9.3.5.1.Market size analysis, by Companion Type
9.3.5.2.Market size analysis, by Arthritis Type
9.3.5.3.Market size analysis, by Treatment
9.3.5.4.Market size analysis, by Distribution Channel

9.3.6.Rest of Asia-Pacific

9.3.6.1.Market size analysis, by Companion Type
9.3.6.2.Market size analysis, by Arthritis Type
9.3.6.3.Market size analysis, by Treatment
9.3.6.4.Market size analysis, by Distribution Channel

9.3.7.Research Dive Exclusive Insights

9.3.7.1.Market attractiveness
9.3.7.2.Competition heatmap

9.4.LAMEA

9.4.1.Brazil

9.4.1.1.Market size analysis, by Companion Type
9.4.1.2.Market size analysis, by Arthritis Type
9.4.1.3.Market size analysis, by Treatment
9.4.1.4.Market size analysis, by Distribution Channel

9.4.2.Saudi Arabia

9.4.2.1.Market size analysis, by Companion Type
9.4.2.2.Market size analysis, by Arthritis Type
9.4.2.3.Market size analysis, by Treatment
9.4.2.4.Market size analysis, by Distribution Channel

9.4.3.UAE

9.4.3.1.Market size analysis, by Companion Type
9.4.3.2.Market size analysis, by Arthritis Type
9.4.3.3.Market size analysis, by Treatment
9.4.3.4.Market size analysis, by Distribution Channel

9.4.4.South Africa

9.4.4.1.Market size analysis, by Companion Type
9.4.4.2.Market size analysis, by Arthritis Type
9.4.4.3.Market size analysis, by Treatment
9.4.4.4.Market size analysis, by Distribution Channel

9.4.5.Rest of LAMEA

9.4.5.1.Market size analysis, by Companion Type
9.4.5.2.Market size analysis, by Arthritis Type
9.4.5.3.Market size analysis, by Treatment
9.4.5.4.Market size analysis, by Distribution Channel

9.4.6.Research Dive Exclusive Insights

9.4.6.1.Market attractiveness
9.4.6.2.Competition heatmap

10.Competitive Landscape

10.1.Top winning strategies, 2021

10.1.1.By strategy
10.1.2.By year
10.2.Strategic overview
10.3.Market share analysis, 2021

11.Company Profiles

11.1.Zoetis

11.1.1.Overview
11.1.2.Business segments
11.1.3.Product portfolio
11.1.4.Financial performance
11.1.5.Recent developments
11.1.6.SWOT analysis

11.2.Elanco

11.2.1.Overview
11.2.2.Business segments
11.2.3.Product portfolio
11.2.4.Financial performance
11.2.5.Recent developments
11.2.6.SWOT analysis

11.3.Virbac

11.3.1.Overview
11.3.2.Business segments
11.3.3.Product portfolio
11.3.4.Financial performance
11.3.5.Recent developments
11.3.6.SWOT analysis

11.4.Dechra

11.4.1.Overview
11.4.2.Business segments
11.4.3.Product portfolio
11.4.4.Financial performance
11.4.5.Recent developments
11.4.6.SWOT analysis

11.5.Vetoquinol

11.5.1.Overview
11.5.2.Business segments
11.5.3.Product portfolio
11.5.4.Financial performance
11.5.5.Recent developments
11.5.6.SWOT analysis

11.6.Phibro Animal

11.6.1.Overview
11.6.2.Business segments
11.6.3.Product portfolio
11.6.4.Financial performance
11.6.5.Recent developments
11.6.6.SWOT analysis

11.7.Boehringer Ingelheim

11.7.1.Overview
11.7.2.Business segments
11.7.3.Product portfolio
11.7.4.Financial performance
11.7.5.Recent developments
11.7.6.SWOT analysis

11.8.NexGen Pharmaceuticals

11.8.1.Overview
11.8.2.Business segments
11.8.3.Product portfolio
11.8.4.Financial performance
11.8.5.Recent developments
11.8.6.SWOT analysis

11.9.Ceva

11.9.1.Overview
11.9.2.Business segments
11.9.3.Product portfolio
11.9.4.Financial performance
11.9.5.Recent developments
11.9.6.SWOT analysis

11.10.Ceva

11.10.1.Overview
11.10.2.Business segments
11.10.3.Product portfolio
11.10.4.Financial performance
11.10.5.Recent developments
11.10.6.SWOT analysis

12.Appendix

12.1.Parent & peer market analysis
12.2.Premium insights from industry experts
12.3.Related reports



★調査レポート[世界のコンパニオンアニマル関節炎市場2022年-2031年：コンパニオン種類別（犬、猫、馬）、関節炎種類別（変形性関節症、関節リウマチ）、治療別（運動、医療、その他）、流通チャネル別（オンラインストア、ペット用品店、動物病院＆診療所、その他）] (コード：RDV23MA018)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のコンパニオンアニマル関節炎市場2022年-2031年：コンパニオン種類別（犬、猫、馬）、関節炎種類別（変形性関節症、関節リウマチ）、治療別（運動、医療、その他）、流通チャネル別（オンラインストア、ペット用品店、動物病院＆診療所、その他）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のコンパニオンアニマル関節炎市場2021-2031：コンパニオン種類別（犬、猫、馬）、関節炎種類別（変形性関節症、関節リウマチ）、治療法別（運動、医療、その他）、流通チャネル別（オンラインストア、ペット用品店、動物病院・診療所、その他）
  • 世界のペット用機能性おやつ市場2021-2031：ペット別（犬、猫、その他）、用途別（骨健康、脳健康、肥満、皮膚疾患、その他）、流通チャネル別（ペットショップ、薬局、動物病院、オンラインストア、その他）
  • 世界のコンパニオンアニマル医薬品市場（～2027年）：動物種別（犬、猫、馬）、投与経路別（経口、注射、局所）、疾患別（抗生物質、寄生虫）、流通チャネル別（動物病院、クリニック）、地域別
  • 世界の動物用歯科機器市場2023年-2032年：製品別（手用器具、機器、消耗品）、動物の種類別（大型動物、小動物）、エンドユーザー別（動物病院、動物病院、その他）
  • 世界の抗核抗体検査市場2022年-2031年：製品別（試薬＆アッセイキット、システム/ソフトウェア/サービス）、技術別（ELISA、免疫蛍光アッセイ、マルチプレックスアッセイ）、用途別（関節リウマチ、全身性エリテマトーデス、シェーグレン症候群、強皮症、その他）、最終用途別（病院、臨床研究所、医師オフィス研究所、その他）、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）
  • 世界のプレフィルドオートインジェクター（薬剤充填済み自動注射器）市場2023-2033：疾患別（アナフィラキシー、多発性硬化症、関節リウマチ）、流通チャネル別（病院薬局、小売薬局、オンライン薬局、ドラッグストア）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆